|
Alzheimer Disease
Contributing journals to this collection:
JAMA & Archives Journals
Citations 151-160 of 695 total displayed.
- Original Articles
Clinical Prediction of Alzheimer Disease Dementia Across the Spectrum of Mild Cognitive Impairment
- Bradford C. Dickerson; Reisa A. Sperling; Bradley T. Hyman; Marilyn S. Albert; Deborah Blacker
Arch Gen Psychiatry 2007; 64: 1443-1450.
[Abstract]
[Full text]
[PDF]
- Clinical Implications of Basic Neuroscience Research
Functional Implication of the Vitamin A Signaling Pathway in the Brain
- Mehdi Tafti; Norbert B. Ghyselinck
Arch Neurol 2007; 64: 1706-1711.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Hypertension and the Risk of Mild Cognitive Impairment
- Christiane Reitz; Ming-Xin Tang; Jennifer Manly; Richard Mayeux; José A. Luchsinger
Arch Neurol 2007; 64: 1734-1740.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Variability of Age at Onset in Siblings With Familial Alzheimer Disease
- Estrella Gómez-Tortosa; M. Sagrario Barquero; Manuel Barón; M. Jose Sainz; Sagrario Manzano; Maria Payno; Raquel Ros; Carmen Almaraz; Pilar Gómez-Garré; Adriano Jiménez-Escrig
Arch Neurol 2007; 64: 1743-1748.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Leisure Activity and Cognitive Decline in Incident Alzheimer Disease
- Elizabeth P. Helzner; Nikolaos Scarmeas; Stephanie Cosentino; Florence Portet; Yaakov Stern
Arch Neurol 2007; 64: 1749-1754.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Disruptive Behavior as a Predictor in Alzheimer Disease
- Nikolaos Scarmeas; Jason Brandt; Deborah Blacker; Marilyn Albert; Georgios Hadjigeorgiou; Bruno Dubois; Davangere Devanand; Lawrence Honig; Yaakov Stern
Arch Neurol 2007; 64: 1755-1761.
[Abstract]
[Full text]
[PDF]
- Original Contributions
 7 Nicotinic Receptor Up-regulation in Cholinergic Basal Forebrain Neurons in Alzheimer Disease
- Scott E. Counts; Bin He; Shaoli Che; Milos D. Ikonomovic; Steven T. DeKosky; Stephen D. Ginsberg; Elliott J. Mufson
Arch Neurol 2007; 64: 1771-1776.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Candidate Single-Nucleotide Polymorphisms From a Genomewide Association Study of Alzheimer Disease
- Hao Li; Sally Wetten; Li Li; Pamela L. St. Jean; Ruchi Upmanyu; Linda Surh; David Hosford; Michael R. Barnes; James David Briley; Michael Borrie; Natalie Coletta; Richard Delisle; Daniella Dhalla; Margaret G. Ehm; Howard H. Feldman; Luis Fornazzari; Serge Gauthier; Neil Goodgame; Danilo Guzman; Sandra Hammond; Paul Hollingworth; Ging-Yuek Hsiung; Joan Johnson; Devon D. Kelly; Ron Keren; Andrew Kertesz; Karen S. King; Simon Lovestone; Inge Loy-English; Paul M. Matthews; Michael J. Owen; Mary Plumpton; William Pryse-Phillips; Rab K. Prinjha; Jill C. Richardson; Ann Saunders; Andrew J. Slater; Peter H. St. George-Hyslop; Sandra W. Stinnett; Jina E. Swartz; Rachel L. Taylor; John Wherrett; Julie Williams; David P. Yarnall; Rachel A. Gibson; Michael C. Irizarry; Lefkos T. Middleton; Allen D. Roses
Arch Neurol 2007.3.
[Abstract]
[Full text]
[PDF]
- Original Articles
Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease
- Robert A. Rosenheck; Douglas L. Leslie; Jody L. Sindelar; Edward A. Miller; Peter N. Tariot; Karen S. Dagerman; Sonia M. Davis; Barry D. Lebowitz; Peter Rabins; John K. Hsiao; Jeffery A. Lieberman; Lon S. Schneider; for the Clinical Antipsychotic Trial of Intervention Effectiveness–Alzheimer's Disease (CATIE-AD) investigators
Arch Gen Psychiatry 2007; 64: 1259-1268.
[Abstract]
[Full text]
[PDF]
- Research Letters
Statins Differentially Affect Amyloid Precursor Protein Metabolism in Presymptomatic PS1 and Non-PS1 Subjects
- Douglas A. Hinerfeld; Majaz Moonis; Joan M. Swearer; Stephen P. Baker; Richard J. Caselli; Ekaterina Rogaeva; Peter St. George-Hyslop; Daniel A. Pollen
Arch Neurol 2007; 64: 1672-1673.
[Extract]
[Full text]
[PDF]
|
Advertisement
|
|
|
